logobest_018

Noteworthy

Joanna Streck, pre-doc fellow, has received the CPDD 2017 Women & Sex/Gender Junior Investigator Travel Award.

Andrea Villanti, Ph.D., has been awarded the SRNT 2018 Jarvik-Russell Early Career Award, honoring members early in their careers who have made extraordinary contributions to the field of nicotine and tobacco research.

Allison N. Kurti, Ph.D., joins the VCBH as an assistant professor. Kurti recently completed her postdoc fellowship with VCBH. 

Stephen T. Higgins, Ph.D., has earned the 2017 Mentorship Award from the College on Problems of Drug Dependence. This award, established in 2000, is given annually to a member of CPDD who has been an exemplary mentor to developing researchers in the field of drug dependence.   

Nancy S. Bercaw, VCBH Communications Specialist, is the author of a new memoir, "DRYLAND: One Woman's Swim to Sobriety," published by Grand Harbor Press, April 2017. 

John Hughes, M.D., has been named to the inaugural class of SRNT fellows, conferred in recognition of his outstanding contributions to the field. He also garnered the ATTUD Excellence in Tobacco Treatment, Training and Advocacy Award last year which subsequently been renamed “The John R Hughes ATTUD Excellence in Tobacco Treatment, Training and Advocacy Award."

Elias Klemperer, predoctoral fellow, has earned a NIDA Director’s Travel Award for his upcoming presentation at the 79th Annual CPDD Conference. Klemperer was also featured in a SEVEN DAYS article about UVM psychologists bringing therapy to federal prisoners.

Publications

UVM TCORS 

UVM COBRE

VCBH Research News

Former Pre-Doc Awarded FDA Tobacco Regulatory Science Fellowship

mollie_03Mollie Miller, Ph.D., a postdoctoral research associate with UVM TCORS at Brown University, has been awarded a Tobacco Regulatory Science Fellowship at the Food and Drug Administration Center for Tobacco Products, Office of Science. Miller earned her Masters and Doctoral degrees in Experimental Psychology from the University of Vermont, where she was predoctoral fellow. “I am very excited for the CTP fellowship and it's directly in line with where I hope to take my career,” Miller says of the award. “I am also able to remain affiliated with TCORS and the tobacco research community.”

Pre-Doc Fellow Earns "Most Innovative Research" Award

Klemperer AwardElias Klemperer, predoctoral fellow with the VCBH, was honored by UVM's Graduate School Senate with the "Most Innovative Research" Award at the organization's annual dinner on May 5, 2017. The Award is given to a graduate student whose research is “unique, progressive, and exemplary of the cutting-edge research being completed at the University of Vermont.” Klemperer was recognized for his studies of how smoking reduction can serve as a stepping stone to later cessation.

Ades' Cardiac Rehab Expertise Featured in Consumer Reports 

Ades Endowed Professor

VCBH Associate Director and UVM Professor of Cardiovascular Medicine Philip Ades, M.D., provided his cardiac rehab expertise for a recent Consumer Reports Health article entitled, "What's Missing from Your Heart-Attack Recovery Plan." Part of the problem, as Ades explains, is the lack of geographically available options. "There are too few in many big cities, and in rural areas you could be a 3-hour drive from the nearest cardiac rehabilitation center,” he says. “Even small improvements in physical function can greatly improve quality of life and self-esteem, and lead to overall better health."

Rawson Talks “Sobering Truth about Addiction Treatment in America” in Psychology Today

A recent article by David Sheff in Psychology Today explores a lingering question about the opioid epidemic: addiction is treatable, so why aren’t more people receiving quality care? A VCBH researcher, with global experience in treatment, offered his expertise regarding shortcomings for patients in care. “They are denied life-saving medications by practitioners who don’t believe in them—as Richard Rawson, PhD, research professor, UVM Center for Behavior and Health, says, 'this is tantamount to a doctor not believing in Coumadin to prevent heart attacks or insulin for diabetes.'” Read the full article here.

Vaping & Withdrawal: Exploring Responses to Quitting E-Cigs

“Electronic cigarettes are currently the fastest-growing tobacco harm-reduction product,” says VCBH researcher and Larner College of Medicine Psychiatry Professor John Hughes, M.D., who is leading a new study to determine whether or not stopping e-cigarettes will lead to withdrawal symptoms. Hughes’ lab, in partnership with Battelle Public Health Center for Tobacco Research Laboratory in Baltimore, Md., is in the process of recruiting 120 long-term users of e-cigarettes for the National Cancer Institute-funded study.  Screening for participant eligibility is available to Vermont residents through the study’s website. Also, watch the WCAX interview with Dr. Hughes about the study. 

Rawson Part of Opioid Panel at Clinton Health Summit 

On Monday, April 10, President Bill Clinton and three panelists -- including VCBH Research Professor Richard Rawson, Ph.D. -- discussed ways to help "Catalyze Solutions to the Opioid Epidemic." Dr. Rawson is currently working with the Vermont Department of Health on a "Hub and Spoke Model" for addiction treatment in the state. In his remarks at the Summit, Rawson said the treatment options out there are effective, but sometimes inaccessible. “Treating this is less complicated then treating diabetes, and it’s less complicated than treating many types of cardiovascular disease and hypertension,” he commented. “They are very effective and they are saving thousands of lives; we just need to get people access to these treatments."